Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bioengineering
Biotech
Discreet biotech Osanni Bio starts making noise with $190M
Osanni launched three years ago with a $27 million series A and has kept purposefully quiet ever since.
Darren Incorvaia
Jun 23, 2026 2:28pm
AACR: Genentech veteran engineers ‘smart’ cancer drug startup
Apr 19, 2026 6:05pm
United Therapeutics' temporary liver shows promise in trial
Jan 27, 2026 9:00am
eGenesis announces 2nd pig kidney transplant success
Feb 7, 2025 2:10pm
FDA approves Humacyte’s off-the-shelf artery for trauma repairs
Dec 23, 2024 10:36am
Synthetic sticky molecules could bind cells and build organs
Dec 13, 2022 9:29am
